scholarly journals Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial

2018 ◽  
Vol 21 (1) ◽  
pp. 136-145 ◽  
Author(s):  
Kohei Kaku ◽  
Masakazu Haneda ◽  
Yuko Tanaka ◽  
Ganghyuck Lee ◽  
Kosuke Shiki ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document